(BA) The Boeing - Ratings and Ratios
Jetliners, Military-Aircraft, Satellites, Spaceflight-Systems, Services
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 32.5% |
| Value at Risk 5%th | 50.5% |
| Relative Tail Risk | -5.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.69 |
| Alpha | 5.62 |
| CAGR/Max DD | 0.02 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.431 |
| Beta | 1.179 |
| Beta Downside | 1.317 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.31% |
| Mean DD | 21.04% |
| Median DD | 21.61% |
Description: BA The Boeing September 24, 2025
Boeing (NYSE: BA) operates through three core segments: Commercial Airplanes, which designs, builds, and sells passenger and cargo jets; Defense, Space & Security, which develops military aircraft, missiles, cyber-and-intelligence systems, and satellite platforms; and Global Services, which provides aftermarket support such as maintenance, training, supply-chain logistics, and digital analytics to both commercial and defense customers.
As of the most recent 2023 10-K, the Commercial Airplanes segment reported a backlog of roughly $480 billion, supporting an annual delivery target of ~800 jets in 2024, while Defense, Space & Security generated $46 billion in revenue, driven by rising U.S. defense spending and international export contracts. Global Services contributed a 14 % EBIT margin, reflecting higher recurring revenue from long-term service agreements.
Key macro drivers include the post-COVID rebound in airline passenger traffic (global RPK growth of ~7 % YoY in Q2 2024), tightening aerospace supply chains that affect delivery schedules, and sustained increases in U.S. and allied defense budgets (FY 2025 defense appropriations up 3.5 % year-over-year). Conversely, fuel price volatility and regulatory scrutiny of aircraft safety remain material risks.
For a deeper, data-rich assessment of Boeing’s valuation dynamics and scenario analysis, you may find the research tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-9.85b TTM) > 0 and > 6% of Revenue (6% = 4.85b TTM) |
| FCFTA -0.03 (>2.0%) and ΔFCFTA 2.14pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.29% (prev 16.56%; Δ 6.73pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.02 (>3.0%) and CFO -3.72b > Net Income -9.85b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.18 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (756.7m) change vs 12m ago 22.27% (target <= -2.0% for YES) |
| Gross Margin 1.15% (prev 3.16%; Δ -2.01pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 56.14% (prev 53.23%; Δ 2.91pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -2.41 (EBITDA TTM -4.98b / Interest Expense TTM 2.87b) >= 6 (WARN >= 3) |
Altman Z'' 0.72
| (A) 0.13 = (Total Current Assets 122.13b - Total Current Liabilities 103.32b) / Total Assets 150.02b |
| (B) 0.06 = Retained Earnings (Balance) 9.12b / Total Assets 150.02b |
| (C) -0.05 = EBIT TTM -6.91b / Avg Total Assets 143.86b |
| (D) 0.02 = Book Value of Equity 3.63b / Total Liabilities 158.28b |
| Total Rating: 0.72 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 31.76
| 1. Piotroski 1.0pt |
| 2. FCF Yield -2.51% |
| 3. FCF Margin -5.93% |
| 4. Debt/Equity -6.47 |
| 5. Debt/Ebitda -9.47 |
| 6. ROIC - WACC (= -22.46)% |
| 7. RoE 209.8% |
| 8. Rev. Trend 59.68% |
| 9. EPS Trend -4.80% |
What is the price of BA shares?
Over the past week, the price has changed by +5.52%, over one month by -5.98%, over three months by -20.38% and over the past year by +20.74%.
Is BA a buy, sell or hold?
- Strong Buy: 16
- Buy: 4
- Hold: 9
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the BA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 245 | 29.6% |
| Analysts Target Price | 245 | 29.6% |
| ValueRay Target Price | 194.2 | 2.7% |
BA Fundamental Data Overview November 29, 2025
P/E Forward = 92.5926
P/S = 1.7789
P/EG = 6.5305
Beta = 1.17
Revenue TTM = 80.76b USD
EBIT TTM = -6.91b USD
EBITDA TTM = -4.98b USD
Long Term Debt = 44.61b USD (from longTermDebt, last quarter)
Short Term Debt = 8.74b USD (from shortTermDebt, last quarter)
Debt = 53.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 47.18b USD (from netDebt column, last quarter)
Enterprise Value = 190.84b USD (143.66b + Debt 53.35b - CCE 6.17b)
Interest Coverage Ratio = -2.41 (Ebit TTM -6.91b / Interest Expense TTM 2.87b)
FCF Yield = -2.51% (FCF TTM -4.79b / Enterprise Value 190.84b)
FCF Margin = -5.93% (FCF TTM -4.79b / Revenue TTM 80.76b)
Net Margin = -12.20% (Net Income TTM -9.85b / Revenue TTM 80.76b)
Gross Margin = 1.15% ((Revenue TTM 80.76b - Cost of Revenue TTM 79.83b) / Revenue TTM)
Gross Margin QoQ = -10.21% (prev 10.77%)
Tobins Q-Ratio = 1.27 (Enterprise Value 190.84b / Total Assets 150.02b)
Interest Expense / Debt = 1.30% (Interest Expense 694.0m / Debt 53.35b)
Taxrate = -2.69% (negative due to tax credits) (140.0m / -5.20b)
NOPAT = -7.10b (EBIT -6.91b * (1 - -2.69%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 1.18 (Total Current Assets 122.13b / Total Current Liabilities 103.32b)
Debt / Equity = -6.47 (negative equity) (Debt 53.35b / totalStockholderEquity, last quarter -8.25b)
Debt / EBITDA = -9.47 (negative EBITDA) (Net Debt 47.18b / EBITDA -4.98b)
Debt / FCF = -9.85 (negative FCF - burning cash) (Net Debt 47.18b / FCF TTM -4.79b)
Total Stockholder Equity = -4.69b (last 4 quarters mean from totalStockholderEquity)
RoA = -6.57% (Net Income -9.85b / Total Assets 150.02b)
RoE = 209.8% (negative equity) (Net Income TTM -9.85b / Total Stockholder Equity -4.69b)
RoCE = -17.31% (EBIT -6.91b / Capital Employed (Equity -4.69b + L.T.Debt 44.61b))
RoIC = -14.55% (negative operating profit) (NOPAT -7.10b / Invested Capital 48.78b)
WACC = 7.92% (E(143.66b)/V(197.01b) * Re(10.36%) + D(53.35b)/V(197.01b) * Rd(1.30%) * (1-Tc(-0.03)))
Discount Rate = 10.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 11.42%
Fair Price DCF = unknown (Cash Flow -4.79b)
EPS Correlation: -4.80 | EPS CAGR: 1.92% | SUE: -4.0 | # QB: 0
Revenue Correlation: 59.68 | Revenue CAGR: 12.84% | SUE: 2.02 | # QB: 2
EPS next Quarter (2026-03-31): EPS=-0.01 | Chg30d=-0.452 | Revisions Net=-6 | Analysts=12
EPS current Year (2025-12-31): EPS=-9.44 | Chg30d=-5.530 | Revisions Net=-15 | Growth EPS=+53.7% | Growth Revenue=+32.4%
EPS next Year (2026-12-31): EPS=2.54 | Chg30d=-0.814 | Revisions Net=-10 | Growth EPS=+126.9% | Growth Revenue=+9.3%
Additional Sources for BA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle